All

Review of many clinical trials which attest to the risk of hypertriglyceridemia

0
No votes yet

Monoclonal Antibodies (mAbs): Three Decades of Innovation and Progress   Faculty: Eli M. Roth MD, FACC, FNLA Medical Director, Sterling Research Group Professor of Clinical Medicine, University of Cincinnati Where: Grand Cypress Ballroom G When: May 2nd, 2014 at 11:35AM-12:... more

0
No votes yet

Responses from healthcare workers show significant barriers to prescriptions PCSK9 Inhibitors Survey Findings Infographic Download PCSK9 Inhibitors Approval Checklist Download JACKSONVILLE, Fla. — The National Lipid Association (NLA) released on Wednesday the results of its survey on... more

Section:

0
No votes yet

This issue is sponsored by the Southwest Lipid Association

0
No votes yet

DS: Thank you for joining me today Fran. First, I would like to introduce myself and then you to the LipidSpin readers. I am Dan Soffer, a full-time internist, clinical lipidologist and educator at the University of Pennsylvania. I am also President-Elect of the Northeast Lipid Association (NELA)... more

0
No votes yet

The National Lipid Association (NLA) is seeking nominations for the Chief Science Officer (CSO) position for the 2017-2020 term, beginning at the 2017 NLA annual Scientific Sessions and ending at the conclusion of the 2020 annual Scientific Sessions.  The nomination requirements,... more

Terms and Conditions By registering for the NLA Scientific Sessions, you agree to the following Terms and Conditions: Registration Information By registering for the NLA Scientific Sessions, the attendee understands and agrees that the attendee’s full contact information will be shared with... more

All issues of LipidSpin are special, but this one is particularly so since it was co-developed by the Southeast and Northeast Chapters of the National Lipid Association. It was a real pleasure working with Dr. Karen Aspry, Northeast Chapter President, on this important and timely issue. Although... more

0
No votes yet

Since loss-of-function mutations in proprotein convertase subtilisin-kexin type 9 (PCSK9) were found to be associated with reduction in low-density lipoprotein cholesterol levels (LDL-C) and coronary events1, there has been great anticipation of the development of effective therapeutic agents to... more

0
No votes yet

Medication Adherence Medication adherence is a vital part of managing a patient’s medication regimen but is often overlooked. Between addressing patient symptoms, assessing vital signs, and dispensing medications, healthcare providers have several tasks to address during a patient encounter.... more

0
No votes yet